Nicholas A. Smith

Array ( [id] => 4745290 [patent_doc_number] => 20080089892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Fc Region Variants' [patent_app_type] => utility [patent_app_number] => 10/584692 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 48065 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089892.pdf [firstpage_image] =>[orig_patent_app_number] => 10584692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045128 [patent_doc_number] => 20050249723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Fc polypeptides with novel Fc ligand binding sites' [patent_app_type] => utility [patent_app_number] => 11/022289 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 34992 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249723.pdf [firstpage_image] =>[orig_patent_app_number] => 11022289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182762 [patent_doc_number] => 20050191293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'IP-10 antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 11/009731 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 38735 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191293.pdf [firstpage_image] =>[orig_patent_app_number] => 11009731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842194 [patent_doc_number] => 20060121023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method to decrease nonspecific staining by Cy5' [patent_app_type] => utility [patent_app_number] => 11/005886 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5588 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121023.pdf [firstpage_image] =>[orig_patent_app_number] => 11005886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802554 [patent_doc_number] => 20080014141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Substance Binding Human Igg Fc Receptor Iib (Fcyriib)' [patent_app_type] => utility [patent_app_number] => 10/580813 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9571 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014141.pdf [firstpage_image] =>[orig_patent_app_number] => 10580813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068861 [patent_doc_number] => 20070189962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Mutated anti-cd22 antibodies and immunoconjugates' [patent_app_type] => utility [patent_app_number] => 10/580635 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26970 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20070189962.pdf [firstpage_image] =>[orig_patent_app_number] => 10580635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7178454 [patent_doc_number] => 20050124041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same' [patent_app_type] => utility [patent_app_number] => 10/988617 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3777 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124041.pdf [firstpage_image] =>[orig_patent_app_number] => 10988617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999333 [patent_doc_number] => 20070041967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Igg fc fragment for a drug carrier and method for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/535341 [patent_app_country] => US [patent_app_date] => 2004-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22003 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041967.pdf [firstpage_image] =>[orig_patent_app_number] => 10535341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720786 [patent_doc_number] => 20060073561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => '157 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 10/986405 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 307474 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073561.pdf [firstpage_image] =>[orig_patent_app_number] => 10986405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938567 [patent_doc_number] => 20050112130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Enhanced B cell cytotoxicity of CDIM binding antibody' [patent_app_type] => utility [patent_app_number] => 10/982698 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21425 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112130.pdf [firstpage_image] =>[orig_patent_app_number] => 10982698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142786 [patent_doc_number] => 20050118174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 10/982470 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40244 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118174.pdf [firstpage_image] =>[orig_patent_app_number] => 10982470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142754 [patent_doc_number] => 20050118155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/981678 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20658 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118155.pdf [firstpage_image] =>[orig_patent_app_number] => 10981678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7195944 [patent_doc_number] => 20050164245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/971001 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 19053 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164245.pdf [firstpage_image] =>[orig_patent_app_number] => 10971001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951770 [patent_doc_number] => 20050226864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Alteration of Fc-fusion protein serum half-lives by mutagenesis' [patent_app_type] => utility [patent_app_number] => 10/966673 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21246 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226864.pdf [firstpage_image] =>[orig_patent_app_number] => 10966673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719362 [patent_doc_number] => 20080241884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Fused Protein Composition' [patent_app_type] => utility [patent_app_number] => 10/575261 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 63376 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241884.pdf [firstpage_image] =>[orig_patent_app_number] => 10575261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977422 [patent_doc_number] => 20050287138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'CCR4-specific antibody composition' [patent_app_type] => utility [patent_app_number] => 10/959310 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 38386 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287138.pdf [firstpage_image] =>[orig_patent_app_number] => 10959310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6960034 [patent_doc_number] => 20050215768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Polypeptides including modified constant regions' [patent_app_type] => utility [patent_app_number] => 10/959318 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9430 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215768.pdf [firstpage_image] =>[orig_patent_app_number] => 10959318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252653 [patent_doc_number] => 20050142609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Native immunoglobulin binding reagents and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 10/960442 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19816 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142609.pdf [firstpage_image] =>[orig_patent_app_number] => 10960442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938556 [patent_doc_number] => 20050112119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Antibodies which bind human CXCR3' [patent_app_type] => utility [patent_app_number] => 10/949135 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19818 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112119.pdf [firstpage_image] =>[orig_patent_app_number] => 10949135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7192664 [patent_doc_number] => 20050163708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Chimeric antibody with specificity to human B cell surface antigen' [patent_app_type] => utility [patent_app_number] => 10/941768 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10765 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163708.pdf [firstpage_image] =>[orig_patent_app_number] => 10941768 [rel_patent_id] =>[rel_patent_doc_number] =>)